Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome

JP Habashi, DP Judge, TM Holm, RD Cohn, BL Loeys… - Science, 2006 - science.org
Aortic aneurysm and dissection are manifestations of Marfan syndrome (MFS), a disorder
caused by mutations in the gene that encodes fibrillin-1. Selected manifestations of MFS reflect …

Post-translational disruption of dystroglycan–ligand interactions in congenital muscular dystrophies

DE Michele, R Barresi, M Kanagawa, F Saito, RD Cohn… - Nature, 2002 - nature.com
Muscle–eye–brain disease (MEB) and Fukuyama congenital muscular dystrophy (FCMD)
are congenital muscular dystrophies with associated, similar brain malformations 1 , 2 . The …

Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states

RD Cohn, C Van Erp, JP Habashi, AA Soleimani… - Nature medicine, 2007 - nature.com
Skeletal muscle has the ability to achieve rapid repair in response to injury or disease 1 . Many
individuals with Marfan syndrome (MFS), caused by a deficiency of extracellular fibrillin-1…

Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test

…, PN Ray, S Bowdin, MS Meyn, RD Cohn… - Genetics in …, 2018 - nature.com
Purpose Genetic testing is an integral diagnostic component of pediatric medicine. Standard
of care is often a time-consuming stepwise approach involving chromosomal microarray …

Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy

…, J Chen, DE Michele, MD Henry, A Messing, RD Cohn… - Nature, 2002 - nature.com
Fukuyama congenital muscular dystrophy (FCMD), muscle–eye–brain disease (MEB), and
Walker–Warburg syndrome are congenital muscular dystrophies (CMDs) with associated …

Molecular basis of muscular dystrophies

RD Cohn, KP Campbell - Muscle & nerve, 2000 - Wiley Online Library
Muscular dystrophies represent a heterogeneous group of disorders, which have been largely
classified by clinical phenotype. In the last 10 years, identification of novel skeletal muscle …

Noncanonical TGFβ signaling contributes to aortic aneurysm progression in Marfan syndrome mice

…, ME Lindsay, D Kim, F Schoenhoff, RD Cohn… - Science, 2011 - science.org
Transforming growth factor–β (TGFβ) signaling drives aneurysm progression in multiple
disorders, including Marfan syndrome (MFS), and therapies that inhibit this signaling cascade …

[HTML][HTML] Disruption of the sarcoglycan–sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy

R Coral-Vazquez, RD Cohn, SA Moore, JA Hill… - Cell, 1999 - cell.com
To investigate mechanisms in the pathogenesis of cardiomyopathy associated with
mutations of the dystrophin–glycoprotein complex, we analyzed genetically engineered mice …

Whole-genome sequencing expands diagnostic utility and improves clinical management in paediatric medicine

…, PN Ray, MS Meyn, SW Scherer, RD Cohn… - NPJ genomic …, 2016 - nature.com
The standard of care for first-tier clinical investigation of the aetiology of congenital malformations
and neurodevelopmental disorders is chromosome microarray analysis (CMA) for copy…

[HTML][HTML] Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration

RD Cohn, MD Henry, DE Michele, R Barresi, F Saito… - Cell, 2002 - cell.com
Striated muscle-specific disruption of the dystroglycan (DAG1) gene results in loss of the
dystrophin-glycoprotein complex in differentiated muscle and a remarkably mild muscular …